There is no doubt that the biologics market will continue to grow and evolve, and with that growth comes many new opportunities for pharma and biotech companies and the patients they serve. If our industry continues to make quality a core focus in every aspect of the large molecule drug development process, then we will be able to rise to the demands of innovation and deliver more effective, safer therapies for the individuals that need them most.

[EPISODE 24] Dr. David Berkowitz Talks Enzymes, Radiation, And The Lincoln Marathon
On this episode of Molecular Moments, Chad Briscoe speaks with Dr. David Berkowitz, Director of the Division of Chemistry at